{"id":"W4392543341","doi":"10.1182/blood.2023021864","title":"Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sanofi (Canada)","funders":"Genentech; Grifols; Swedish Orphan Biovitrum; CSL Behring; Biogen; Novo Nordisk; Sanofi; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Tolerability; Pre-exposure prophylaxis; Adverse effect; Clinical endpoint; Internal medicine; Hemostasis; Surgery; Clinical trial; Immunology; Human immunodeficiency virus (HIV)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000461682,0.0002792035,0.0006147875,0.00009787916,0.0001240696,0.0004856016,0.0001998838,0.0004017345,0.003862897],"category_scores_gemma":[0.0004996858,0.00009367316,0.0006259045,0.0001370318,0.0001793564,0.0003174458,0.0001545158,0.0008087206,0.0003105619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001903423,"about_ca_system_score_gemma":0.0002219501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003354864,"about_ca_topic_score_gemma":0.0008424252,"domain_scores_codex":[0.999856,0.00007678086,0.000009474696,0.00002156598,0.00001634177,0.00001994888],"domain_scores_gemma":[0.9998281,0.00005005048,0.00005164072,0.00001157711,0.00001198909,0.00004655795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8411993,0.004829628,0.01850912,0.001741751,0.003787383,0.0002143469,0.0001735814,0.0006302165,0.006579557,0.0006779335,0.005709771,0.1159474],"study_design_scores_gemma":[0.7300313,0.1658365,0.0851171,0.0004115513,0.003881861,0.0007026532,0.0001830502,0.001589043,0.001889546,0.0006919132,0.009614954,0.00005059329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876162,0.008472972,0.0001606939,0.0002956823,0.00009294975,0.0002259699,0.0006084227,0.00002806477,0.002499001],"genre_scores_gemma":[0.9944074,0.002704127,0.0002242347,0.0004819361,0.0001199181,0.0002448859,0.0007586332,0.000004136367,0.001054633],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003862897,"threshold_uncertainty_score":0.01292264,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02242289282845604,"score_gpt":0.2848435905269097,"score_spread":0.2624206976984536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}